Pfizer Inc
SIX:PFE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Pfizer Inc
SIX:PFE
|
US |
Intrinsic Value
The intrinsic value of 
Pfizer Inc (PFE) under the Base Case is 23.33 CHF per share.
Compared with the current market price of 30.75 CHF, the stock appears
Overvalued by 24% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Pfizer Does
Pfizer is a global drug company that discovers, develops, makes, and sells prescription medicines and vaccines. It sells treatments in areas such as vaccines, cancer, inflammation, rare diseases, internal medicine, and hospital care. Its customers are doctors, hospitals, pharmacies, governments, and health systems that buy and use its products for patients.
- Headquarters
- United States of America US
- Employees
- 75 000
- IPO date
- Jan 17, 1944
Pfizer has a narrow economic moat
Patents and exclusive rights to sell certain medicines prevent rivals from offering direct copies of important Pfizer treatments. These protections let Pfizer earn more than it could if cheaper copies were freely available, although they protect individual products rather than the entire business.
Read the full moat analysis
Revenue & Expenses Breakdown
Pfizer Inc
Earnings Waterfall
Pfizer Inc
The intrinsic value for Pfizer Inc (PFE) under the Base Case is 23.33 CHF.
Compared with the current market price of 30.75 CHF, the stock appears Overvalued by 24% .
